In our study, we found that JQ1 could block the oncogenic NPM1–c-Myc pathway in vitro and in vivo, which further verified that NPM1 promotes PCa progression by BRD4 mediation and provided more evidence for the future application of JQ1 in PCa patients. This evidence concerns the gene MYC and posterior cortical atrophy.